Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Rilzabrutinib, an Oral BTK Inhibitor, in Immune Thrombocytopenia.
N Engl J Med. 2022 Apr 14;386(15):1421-1431. doi: 10.1056/NEJMoa2110297.
N Engl J Med. 2022.
PMID: 35417637
Clinical Trial.
Choosing and managing a career as a community practitioner.
Regenbogen T.
Regenbogen T.
Clin Adv Hematol Oncol. 2019 Jan;17(1):30-31.
Clin Adv Hematol Oncol. 2019.
PMID: 30843893
No abstract available.
Item in Clipboard
Pacritinib to inhibit JAK/STAT signaling in refractory metastatic colon and rectal cancer.
Regenbogen T, Chen L, Trinkaus K, Wang-Gillam A, Tan BR, Amin M, Pedersen KS, Park H, Suresh R, Lim KH, Ratchford E, Brown A, Lockhart AC.
Regenbogen T, et al.
J Gastrointest Oncol. 2017 Dec;8(6):985-989. doi: 10.21037/jgo.2017.08.16.
J Gastrointest Oncol. 2017.
PMID: 29299358
Free PMC article.
Item in Clipboard
Review of ongoing clinical trials in non-small-cell lung cancer: a status report for 2012 from the ClinicalTrials.gov Web site.
Subramanian J, Regenbogen T, Nagaraj G, Lane A, Devarakonda S, Zhou G, Govindan R.
Subramanian J, et al. Among authors: regenbogen t.
J Thorac Oncol. 2013 Jul;8(7):860-5. doi: 10.1097/JTO.0b013e318287c562.
J Thorac Oncol. 2013.
PMID: 23478543
Free article.
Review.
Item in Clipboard
Cite
Cite